All Stories

  1. Correction: Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction
  2. Two Distinct Transcriptional Subtypes of Severe Type 2 Asthma in NSAID ‐Exacerbated Respiratory Disease
  3. Associations between TNF gene promoter variants (rs361525, rs1800629, rs1799964, rs1799724) and the clinical course of idiopathic inflammatory myopathies
  4. Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction
  5. Circulating B Lymphocyte Subsets in Patients with Systemic Lupus Erythematosus
  6. Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity
  7. Role of Plasma Angiopoietin-1 and VEGF Levels as Potential Biomarkers in Chronic Central Serous Chorioretinopathy with Macular Neovascularization
  8. Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
  9. Circulating Anti-endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
  10. Updates in AERD: What is needed further?
  11. Comprehensive Analysis of Circular RNAs in Endothelial Cells
  12. Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study
  13. Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease
  14. Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD
  15. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis
  16. Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis
  17. Intravenous administration of Tat-NR2B9c peptide, a PSD95 inhibitor, attenuates reinstatement of cocaine-seeking behavior in rats
  18. Dynamic in vitro hemocompatibility of oligoproline self-assembled monolayer surfaces
  19. MiR-191 as a Key Molecule in Aneurysmal Aortic Remodeling
  20. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
  21. The NMDA Receptor Subunit (GluN1 and GluN2A) Modulation Following Different Conditions of Cocaine Abstinence in Rat Brain Structures
  22. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
  23. Endothelial cells response to neutrophil‐derived extracellular vesicles miRNAs in anti‐PR3 positive vasculitis
  24. miRNA Regulation of NK Cells Antiviral Response in Children With Severe and/or Recurrent Herpes Simplex Virus Infections
  25. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
  26. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study
  27. Design, Manufacturing Technology and In-Vitro Evaluation of Original, Polyurethane, Petal Valves for Application in Pulsating Ventricular Assist Devices
  28. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  29. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma
  30. Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
  31. Emerging role of non-coding RNAs in allergic disorders
  32. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs
  33. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  34. Association of Factor V Leiden With Subsequent Atherothrombotic Events
  35. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections
  36. Cocaine Self-Administration and Abstinence Modulate NMDA Receptor Subunits and Active Zone Proteins in the Rat Nucleus Accumbens
  37. Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy
  38. A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
  39. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium
  40. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
  41. Legends of Allergy/Immunology: Andrew Szczeklik
  42. Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort
  43. The interaction of laser radiation with tissue in the aspect of generating the process of decellularization in the preparation of animal origin autologous tissue
  44. Subphenotypes of NSAID‐exacerbated respiratory disease identified by latent class analysis
  45. Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration
  46. LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis
  47. IL-17–high asthma with features of a psoriasis immunophenotype
  48. Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins
  49. Cocaine-induced Changes in the Expression of NMDA Receptor Subunits
  50. Subtypes of eosinophilic asthma with discrete gene pathway phenotypes
  51. A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience
  52. Stratification of asthma phenotypes by airway proteomic signatures
  53. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease
  54. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
  55. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
  56. Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma
  57. Subsequent Event Risk in Individuals With Established Coronary Heart Disease
  58. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti‐inflammatory drug‐induced urticaria
  59. Stabilization of Synthetic Materials with Silver Particles
  60. Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin
  61. Molecular profiling of regulatory T cells in pulmonary sarcoidosis
  62. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
  63. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper
  64. Facilitated expansion of Th17 cells in lupus nephritis patients
  65. Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort
  66. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers
  67. U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes
  68. Eicosanoids and eosinophilic inflammation of airways in stable COPD.
  69. Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA
  70. Correction to: Fibroblast-to-myofibroblast transition in bronchial asthma
  71. Surface modification of metallic materials designed for a new generation of artificial heart valves
  72. Fibroblast-to-myofibroblast transition in bronchial asthma
  73. Aspirin resistance
  74. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome
  75. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis
  76. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma
  77. Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting
  78. Influence of TNF-α promoter variability on stage and grade in individuals with colorectal cancer
  79. miR-200b downregulates CFTR during hypoxia in human lung epithelial cells
  80. Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study
  81. Biomimetics in thin film design: Niche-like wrinkles designed for i-cell progenitor cell differentiation
  82. Respiratory syncytial virus infection influences tight junction integrity
  83. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients
  84. Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects
  85. Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort
  86. Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort
  87. Connexin43 Controls the Myofibroblastic Differentiation of Bronchial Fibroblasts from Patients with Asthma
  88. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
  89. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331
  90. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
  91. Cocaine Administration and Its Withdrawal Enhance the Expression of Genes Encoding Histone-Modifying Enzymes and Histone Acetylation in the Rat Prefrontal Cortex
  92. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis
  93. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
  94. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients
  95. Urinary prostanoids in preschool wheeze
  96. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies
  97. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production
  98. Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology
  99. The genetic evidence for human origin of Jivaroan shrunken heads in collections from the Polish museums
  100. Effect of DHA/EPA supplementation on endothelial damage markers. The bioclaims study
  101. Urinary 11‐Dehydro‐Thromboxane B 2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
  102. Pentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition
  103. Wrinkle-like structures in reconstructing stem cell niches
  104. Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab
  105. Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease
  106. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease
  107. Nanostructural haemocompatible coatings for the internal side of artificial blood vessels
  108. Silver nanoparticles influence on the blood activation process and their release to blood plasma from synthetic polymer scaffold
  109. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
  110. Lesions in the wingless gene of the Apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings, coming from the isolated population in Pieniny (Poland)
  111. Prostaglandin E2in Induced Sputum Following Oralaspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity
  112. Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?
  113. Physicochemical and Biological Investigation of Different Structures of Carbon Coatings Deposited onto Polyurethane
  114. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease
  115. Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma
  116. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier
  117. A lack of Wolbachia-specific DNA in samples from apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings
  118. Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
  119. The first U-BIOPRED sputum handprint of severe asthma
  120. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics
  121. Mortality in end‑stage renal disease: the importance of the genetic background
  122. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema
  123. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia
  124. Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis
  125. T-cell regulation during viral and nonviral asthma exacerbations
  126. Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis
  127. In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  128. Computer engineering in designing and fabrication of tissue analogue-type coating dedicated for the cardiovascular regeneration
  129. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells
  130. Erratum to: A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  131. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency
  132. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients
  133. Unravelling adverse reactions to NSAIDs using systems biology
  134. Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts
  135. Lack of association ofALOX12andALOX15Bpolymorphisms with psoriasis despite altered urinary excretion of 12(S)-hydroxyeicosatetraenoic acid
  136. S65 Urinary Prostaglandins As Inflammatory Markers For Childhood Asthma Exacerbations
  137. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
  138. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
  139. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity
  140. Graphene based porous coatings with antibacterial and antithrombogenous function—Materials and design
  141. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland
  142. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children
  143. AB0029 Imbalance between Immunoregulatory and Effector TH17 Pathway in Active Sle
  144. THU0498 Increase of CXCR3-CCR4+CCR6+CCR10- Memory T Helper Cells (TH17-LIKE) in Patients with Granulomatosis and Polyangiitis (GPA)
  145. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  146. Th2-type cytokine induced mucous metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection
  147. Carbon in airway macrophages from children with asthma
  148. Risk factors for arterial thrombosis in antiphospholipid syndrome
  149. Phagocytosis of fossil fuel particulates by macrophages in children with asthma
  150. Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells
  151. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs
  152. Grubość kompleksu błona wewnętrzna – błona środkowa tętnicy szyjnej koreluje z cechami zespołu metabolicznego u osób młodych z kliniczną diagnozą rodzinnej hipercholesterolemii
  153. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener’s) patients
  154. Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs
  155. Mutations of microsatellite autosomal loci in paternity investigations of the Southern Poland population
  156. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs
  157. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients
  158. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations
  159. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4
  160. Transforming growth factor-β1‑induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients
  161. Exhaled eicosanoid profiles in children with atopic asthma and healthy controls
  162. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients
  163. Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much more: Figure 1–
  164. Biographical memoir: Andrew Szczeklik 29 June 1938–3 February 2012
  165. CCR4-active chemokines contribute to blood and tissue eosinophilia in Churg–Strauss syndrome
  166. Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers
  167. The unfinished history of aspirin hypersensitivity – in memory of Professor Andrew Szczeklik
  168. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome
  169. Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
  170. Nasal Inflammatory Mediators In Non-steroidal Anti-inflammatory Drugs (nsaids) Cross-intolerant Subjects After Lysine Nasal Challenge
  171. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus
  172. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
  173. The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
  174. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  175. Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell–cell contacts
  176. Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration
  177. 832 INTIMA-MEDIA THICKNESS CORRELATES WITH FEATURES OF METABOLIC SYNDROME IN YOUNG PERSONS WITH CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
  178. 592 MUTATION SPECTRUM IN THE LDL RECEPTOR GENE IN PATIENTS FROM THE SOUTH-EASTERN PART OF POLAND
  179. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype
  180. Functional cardio-biomaterials
  181. Coxibs strike back
  182. Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation
  183. Eoxins: A new inflammatory pathway in childhood asthma
  184. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery
  185. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects
  186. Glucocorticoid receptor isoforms in steroid‑dependent asthma
  187. MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATION
  188. Elevated urinary leukotriene E4excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA
  189. Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease
  190. Assessment of hemocompatibility of materials with arterial blood flow by platelet functional tests
  191. Interaction of functionalFCER2promoter polymorphism and phenotype-associated haplotypes
  192. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome
  193. Genetic associations of variants of the high affinity receptor for immunoglobulin E in Wegener’s granulomatosis
  194. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years
  195. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease
  196. Single-stranded conformation polymorphism (SSCP)-driven indirect sequencing in detection of short deletion
  197. Genetic variability of the high-affinity IgE receptor α-subunit (FcεRIα)
  198. FCER1Agene proximal promoter polymorphisms in Caucasians and East Asians
  199. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma
  200. Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome
  201. Two Different Transcription Factors Discriminate the −315C>T Polymorphism of the FcεRIα Gene: Binding of Sp1 to −315C and of a High Mobility Group-Related Molecule to −315T
  202. The Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma
  203. FCER1A gene exon 1A polymorphisms in Japanese and Polish subjects – a comparative analysis of haplotypes
  204. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity
  205. The prevalence of alpha1-antitrypsin deficiency in a representative population sample from Poland
  206. Molecular diagnostics of α1-antitrypsin deficiency
  207. Coding region for the high affinity receptor of immunoglobulin E is highly conservative in allergic patients
  208. Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels
  209. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin
  210. FCERIA gene promoter polymorphisms: Lack of association with aspirin hypersensitivity in whites
  211. GENETIC POLYMORPHISMS OF THE NOVEL FCER1A GENE REGION: RELATION TO TOTAL SERUM IgE LEVELS
  212. Rapid and Inexpensive Detection of α1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening
  213. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease
  214. Genetic Variability of the High-affinity IgE Receptor α Subunit (Fc ε RI α) is Related to Total Serum IgE levels in Allergic Subjects
  215. Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management
  216. NOVEL EXON 2A OF THE HIGH-AFFINITY RECEPTOR FOR THE IgE α-CHAIN GENE (FCER1A) AND AUTOIMMUNITY IN PATIENTS WITH ASTHMA OR URTICARIA
  217. Towards a Multidisciplinary and Integrated Strategy in the Assessment of Adverse Health Effects Related to Air Pollution: The Case Study of Cracow (Poland) and Asthma
  218. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria
  219. The α-chain of high-affinity receptor for IgE (FcɛRIα) gene polymorphisms and serum IgE levels
  220. Towards a multidisciplinary and integrated strategy in the assessment of adverse health effects related to air pollution: The case study of Cracow (Poland) and asthma
  221. Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies
  222. The broken balance in aspirin hypersensitivity
  223. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant
  224. Rhinovirus Infection in Lower Airways of Asthmatic Patients
  225. Reactive Oxygen Species Metabolism and Allergy
  226. Anti-thrombotic action of clopidogrel and PlA1/A2polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin
  227. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism
  228. Aspirin resistance
  229. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma
  230. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib
  231. The dopamine D4 receptor VNTR in Polish schizophrenia patients
  232. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
  233. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
  234. Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
  235. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression
  236. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma
  237. Aspirin intolerance and the cyclooxygenase???leukotriene pathways
  238. X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A "European Community Alport Syndrome Concerted Action" Study
  239. Aspirin and thrombinogenesis
  240. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma
  241. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
  242. 3P-0859 The accuracy of D-dimer testing in patients with venous thromboembolism disease
  243. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist
  244. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease
  245. Repeated imipramine and electroconvulsive shock increase α1A-adrenoceptor mRNA level in rat prefrontal cortex
  246. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors
  247. Montelukast for persistent asthma
  248. Serum interleukin-5 in aspirin-induced asthma
  249. Leukotriene C4 synthase polymorphism and aspirin-induced asthma
  250. Aspirin-induced rhinitis and asthma
  251. Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia
  252. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma
  253. Genetics of aspirin induced asthma
  254. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa
  255. Enhanced Expression of the Leukotriene C4Synthase Due to Overactive Transcription of an Allelic Variant Associated with Aspirin-Intolerant Asthma
  256. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics
  257. X-linked Alport Syndrome
  258. Frequency data on the loci vWA, FES/FPS, F13A01, TH01, TPOX and CSF1P0 in a population from South Poland
  259. Genetic Mechanisms in Aspirin-induced Asthma
  260. Molecular Studies in Osteogenesis Imperfecta (OI)
  261. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma
  262. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation
  263. Data on the loci LDLR, GYPA, HBGG, D7S8 and GC in a South Polish population
  264. Role of leukotrienes in aspirin-induced asthma
  265. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
  266. D1S80 VNTR locus genotypes in population of South Poland; meta-analysis pointer to genetic disequilibrium of human populations
  267. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
  268. Fine deletion mapping of the p22 region of the human X chromosome using a radiation-induced hybrid panel
  269. A gene for achondroplasia–hypochondroplasia maps to chromosome 4p
  270. Limnology Of Missouri Reservoirs: An Analysis of Regional Patterns
  271. Alport syndrome: a genetic study of 31 families
  272. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 collagen gene
  273. 165 MOLECULAR ANALYSIS OF PKU HAPLOTYPES IN THE POPULATION OF SOUTHERN POLAND
  274. 166 TIME-PLACE CLUSTERS ANALYSIS FOR SELECTED CONGENITAL MALFORMATION IN SOUTHERN POLAND
  275. Hypersensitivity to Aspirin and other NSAIDs